Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1152 Results

Title
Intervention Indication Therapeutic Area Year Actions
Bimekizumab for Hidradenitis Suppurativa Bimekizumab (UCB4940) Hidradenitis suppurativa (HS) Dermatology 2022 View  |  Download
Bimekizumab for ankylosing spondylitis Bimekizumab (UCB4940) Ankylosing spondylitis Musculoskeletal System 2021 View  |  Download
Bimekizumab for active psoriatic arthritis Bimekizumab (UCB4940) Psoriatic arthritis Dermatology , Rheumatology 2021 View  |  Download
Bimatoprost slow-release for ocular hypertension or open-angle glaucoma Bimatoprost SR Occular Ocular hypertension Ophthalmology 2021 View  |  Download
BIIB092 for progressive supranuclear palsy Gosuranemab (BIIB092; BMS-986168; IPN007) Progressive supranuclear palsy (PSP) Neurology 2019 View  |  Download
Bifikafusp alfa-onfekafusp alfa neoadjuvant therapy for treating resectable stage IIIB and IIIC melanoma Daromun Melanoma Skin Cancer 2023 View  |  Download
BI 907828 for previously untreated advanced dedifferentiated liposarcoma BI 907828 Advanced dedifferentiated liposarcoma Sarcoma 2023 View  |  Download
BI 1015550 for treating idiopathic pulmonary fibrosis or progressive pulmonary fibrosis BI 1015550 Idiopathic pulmonary fibrosis , Progressive pulmonary fibrosis Respiratory System 2024 View  |  Download
Betula verrucosa for tree pollen allergy-induced moderate to severe rhinoconjunctivitis Birch allergy vaccine (ALK tree AIT; Betula Verrucosa allergen extract) Tree pollen allergy Immunology 2021 View  |  Download
Beremagene geperpavec for dystrophic epidermolysis bullosa Bercolagene telserpavec (Beremagene geperpavec; KB103) Dystrophic epidermolysis bullosa (DEB) Dermatology 2021 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications